v3.26.3
Unaudited Condensed Consolidated Statements of Stockholders’ Equity (Deficit) - USD ($)
$ in Thousands
Total
Common stock
Additional paid-in capital
Accumulated deficit
Balance at beginning (in shares) at Dec. 31, 2024   20,145,129    
Balance at beginning at Dec. 31, 2024 $ 63,144 $ 2 $ 274,895 $ (211,753)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Issuance of common stock in private placement, net of issuance costs (in shares)   1    
Vesting of restricted common stock (in shares)   11,666    
Stock-based compensation expense 861   861  
Net loss (12,433)     (12,433)
Balance at ending (in shares) at Mar. 31, 2025   20,156,796    
Balance at ending at Mar. 31, 2025 51,572 $ 2 275,756 (224,186)
Balance at beginning (in shares) at Dec. 31, 2024   20,145,129    
Balance at beginning at Dec. 31, 2024 63,144 $ 2 274,895 (211,753)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Net loss (40,119)      
Balance at ending (in shares) at Sep. 30, 2025   46,880,185    
Balance at ending at Sep. 30, 2025 58,667 $ 5 310,534 (251,872)
Balance at beginning (in shares) at Mar. 31, 2025   20,156,796    
Balance at beginning at Mar. 31, 2025 51,572 $ 2 275,756 (224,186)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Vesting of restricted common stock (in shares)   4,277    
Stock-based compensation expense 1,002   1,002  
Net loss (12,587)     (12,587)
Balance at ending (in shares) at Jun. 30, 2025   20,161,073    
Balance at ending at Jun. 30, 2025 39,987 $ 2 276,758 (236,773)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Issuance of common stock in private placement, net of issuance costs (in shares)   26,717,414    
Issuance of common stock in private placement, net of issuance costs 29,191 $ 3 29,188  
Issuance of pre-funded warrants in private placement, net of issuance costs 3,601   3,601  
Stock option exercises (in shares)   1,698    
Stock option exercises 3   3  
Stock-based compensation expense 984   984  
Net loss (15,099)     (15,099)
Balance at ending (in shares) at Sep. 30, 2025   46,880,185    
Balance at ending at Sep. 30, 2025 $ 58,667 $ 5 310,534 (251,872)
Balance at beginning (in shares) at Dec. 31, 2025 51,902,614 51,902,614    
Balance at beginning at Dec. 31, 2025 $ 47,704 $ 6 339,854 (292,156)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Issuance of common stock under employee stock purchase plan (in shares)   15,562    
Issuance of common stock under employee stock purchase plan 18   18  
Stock option exercises (in shares)   7,624    
Stock option exercises 39   39  
Stock-based compensation expense 1,472   1,472  
Net loss (18,331)     (18,331)
Balance at ending (in shares) at Mar. 31, 2026   51,925,800    
Balance at ending at Mar. 31, 2026 $ 30,902 $ 6 341,383 (310,487)
Balance at beginning (in shares) at Dec. 31, 2025 51,902,614 51,902,614    
Balance at beginning at Dec. 31, 2025 $ 47,704 $ 6 339,854 (292,156)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Issuance of common stock under employee stock purchase plan (in shares) 45,970      
Net loss $ (80,817)      
Balance at ending (in shares) at Sep. 30, 2026 62,754,200 62,754,200    
Balance at ending at Sep. 30, 2026 $ 107,094 $ 7 480,060 (372,973)
Balance at beginning (in shares) at Mar. 31, 2026   51,925,800    
Balance at beginning at Mar. 31, 2026 30,902 $ 6 341,383 (310,487)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Stock option exercises (in shares)   1,188    
Stock option exercises 4   4  
Stock-based compensation expense 1,931   1,931  
Net loss (33,530)     (33,530)
Balance at ending (in shares) at Jun. 30, 2026   51,926,988    
Balance at ending at Jun. 30, 2026 (693) $ 6 343,318 (344,017)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Issuance of common stock in private placement, net of issuance costs (in shares)   10,795,804    
Issuance of common stock in private placement, net of issuance costs 44,409 $ 1 44,408  
Issuance of pre-funded warrants in private placement, net of issuance costs 90,193   90,193  
Issuance of common stock under employee stock purchase plan (in shares)   30,408    
Issuance of common stock under employee stock purchase plan 113   113  
Stock option exercises (in shares)   1,000    
Stock option exercises 4   4  
Stock-based compensation expense 2,024   2,024  
Net loss $ (28,956)     (28,956)
Balance at ending (in shares) at Sep. 30, 2026 62,754,200 62,754,200    
Balance at ending at Sep. 30, 2026 $ 107,094 $ 7 $ 480,060 $ (372,973)